Stockreport

Medicenna Extends Period to Exercise Certain Warrants

Medicenna Therapeutics Corp. - Common Shares  (MDNA) 
PDF TORONTO and HOUSTON, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immunoth [Read more]